Holen Sie sich die Stockscreener-App
34.80
1.14%
-0.40
Handel nachbörslich:
34.80
Agios Pharmaceuticals Inc Aktie (AGIO) Neueste Nachrichten
Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells $113,848.80 in Stock - marketbeat.com
Agios Pharmaceuticals (NASDAQ:AGIO) CFO Cecilia Jones Sells 3,141 Shares - marketbeat.com
Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells $113,224.02 in Stock - marketbeat.com
AGIO: JP Morgan Raises Price Target to $36, Maintains Neutral Ra - GuruFocus
Jones Cecilia, Agios Pharmaceuticals CFO, sells $109k in stock - Investing.com
Agios (NASDAQ: AGIO) CLO exercises 8,500 PSUs and sells shares for taxes - stocktitan.net
[Form 4] AGIOS PHARMACEUTICALS, INC. Insider Trading Activity - stocktitan.net
Agios (NASDAQ: AGIO) CFO exercises PSUs, automatic share sale for taxes - stocktitan.net
Agios (AGIO) CCO vests 8,500 PSUs, sells 3,262 shares for taxes - stocktitan.net
Agios (NASDAQ: AGIO) exec sells shares to cover PSU tax obligations - stocktitan.net
Agios (AGIO) CEO settles performance units, sells 19K shares to cover taxes - stocktitan.net
JPMorgan Chase & Co. Raises Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $36.00 - marketbeat.com
J.P. Morgan Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Announces Target Price $36 - Moomoo
Short Squeeze: Is Agios Pharmaceuticals Inc stock overvalued or fairly priced2026 Key Highlights & Intraday High Probability Alerts - baoquankhu1.vn
Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET - The Manila Times
Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET - GlobeNewswire Inc.
A Look At Agios Pharmaceuticals (AGIO) Valuation As It Pursues Accelerated FDA Approval For Mitapivat - Sahm
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today - AOL.com
AGIO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Agios Pharmaceuticals, Inc. (AGIO) stock price, news, quote and history - Yahoo Finance Australia
Agios to seek accelerated approval in US of oral mitapivat for SCD - Sickle Cell Disease News
[144] AGIOS PHARMACEUTICALS, INC. SEC Filing - stocktitan.net
AGIO (NASDAQ: AGIO) pre-sale notice — 3,141 RSU shares vesting - stocktitan.net
Insider sale and RSU vesting at AGIO (Nasdaq: AGIO) — 2,959 shares - stocktitan.net
RSU vesting triggers proposed Common Stock sale for AGIO (AGIO) - stocktitan.net
AGIO (NASDAQ: AGIO) affiliate files to sell 2,940 shares after RSU vesting - stocktitan.net
3,280 RSUs vest; James Burns sold 5,218 shares — AGIO (NASDAQ: AGIO) - stocktitan.net
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last? - qz.com
Agios Pharmaceuticals (NASDAQ:AGIO) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says - marketbeat.com
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - The Globe and Mail
AGIO Shares Climb as Mitapivat Advances Toward Fast-Track Approval for SCD - bitget.com
Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - Finviz
A Look At Agios Pharmaceuticals (AGIO) Valuation After Recent Share Price Momentum - Yahoo Finance
Earnings Recap: Is Agios Pharmaceuticals Inc a good ESG investment2026 Sector Review & Fast Moving Trade Plans - baoquankhu1.vn
Agios to pursue accelerated approval for mitapivat in sickle cell By Investing.com - Investing.com South Africa
H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $65 - Moomoo
The Surprise FDA Move That Sent Two Biotechs Rallying - Investor's Business Daily
Why is Agios Pharmaceuticals stock surging Tuesday afternoon? - MSN
Agios (AGIO) Files for Accelerated Approval of Mitapivat in Sick - GuruFocus
Agios Shares Rise After Plans for Accelerated Approval Filing of Mitapivat in Sickle Cell Disease - marketscreener.com
BofA raises Agios Pharma stock price target on SCD filing path By Investing.com - za.investing.com
Why Is Agios Pharmaceuticals Stock Surging Tuesday Afternoon? - Benzinga
BofA raises Agios Pharma stock price target on SCD filing path - au.investing.com
Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap UpHere's Why - marketbeat.com
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High - Benzinga
Truist reiterates Agios Pharma stock rating on accelerated approval path - Investing.com
Agios (AGIO) Sees 13% Boost Following Approval Pursuit for Mitap - GuruFocus
Agios Pharmaceuticals (AGIO) Seeks Accelerated FDA Approval for Sickle Cell Treatment - GuruFocus
Agios gains on plans to seek FDA accelerated nod for Pyrukynd label expansion - Seeking Alpha
AGIO ALERT- The Gross Law Firm Has Commenced an Investigation on Behalf of Agios Pharmaceuticals, Inc. Shareholders Who Lost Money - morningstar.com
Agios stock surges on FDA path for mitapivat approval By Investing.com - Investing.com Canada
Agios to pursue accelerated approval for mitapivat in sickle cell - Investing.com
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):